Skip to main content
Have a personal or library account? Click to login
The optimization of needle electrode number and placement for irreversible electroporation of hepatocellular carcinoma Cover

The optimization of needle electrode number and placement for irreversible electroporation of hepatocellular carcinoma

Open Access
|Apr 2012

References

  1. World health organization: Cancer. World Health Organization. 2012. Accessed: March 12, 2012. Available from:
  2. Gomaa AI, Khan SA, Toledano MB, Waked I, Taylor-Robinson SD. Hepatocellular carcinoma: Epidemiology, risk factors and pathogenesis.2008;: 4300-8
  3. Medicine Net: Liver cancer. Stoppler, M. 2011. Accessed: March 12, 2012. Available from:
  4. Forner A, Llovet JM, Bruix J. Hepatocellular carcinoma.2012; Epub ahead of print.
  5. Davalos RV, Mir IL, Rubinsky B. Tissue ablation with irreversible electroporation.2005;: 223-31.
  6. Daniels C, Rubinsky B. Electrical field and temperature model of nonthermal irreversible electroporation in heterogeneous tissues.2009;: 071006.
  7. Rubinsky B. Irreversible electroporation in medicine.2007;: 255-60.
  8. Rubinsky B, Onik G, Mikus P. Irreversible electroporation: A new ablation modality-clinical implications.2007;: 37-48.
  9. Hofmann GA. Instrumentation and electrodes for in vivo electroporation. In. Jaroszeski MJ, Heller R, Gilbert R, editors.Totowa, New Jersey: Humana Press, 2000. p. 37-61.
  10. Sel D, Mazeres S, Teissie J, Miklavcic D. Finite-element modeling of needle electrodes in tissue from the perspective of frequent model computation.2003;: 1221-32.
  11. Miklavcic D, Beravs K, Semrov D, Cemazar M, Demsar F, Sersa G. The importance of electric field distribution for effective in vivo electroporation of tissues.1998;: 2152-8.
  12. Gilbert RA, Jaroszeski MJ, Heller R. Novel electrode designs for electrochemotherapy.1997;: 9-14.
  13. Sersa G, Cemazar M, Semrov D, Miklavcic D. Changing electrode orientation improves the efficacy of electrochemotherapy of solid tumors in mice.1996;: 61-6.
  14. Corovic S, Pavlin M, Miklavcic D. Analytical and numerical quantification and comparison of the local electric field in the tissue for different electrode configurations.2007;: 37.
  15. Cındea NBF, Gournay F, Poignard C. Optimal placement of electrodes in an electroporation process.2010;: 34-43.
  16. Zupanic A, Corovic S, Miklavcic D. Optimization of electrode position and electric pulse amplitude in electrochemotherapy.2008;: 93-101.
  17. Brandisky K, Daskalov I. Electrical field and current distributions in electrochemotherapy.1999;: 201-8.
  18. Corovic S, Zupanic A, Miklavcic D. Numerical modeling and optimization of electric field distribution in subcutaneous tumor treated with electrochemotherapy using needle electrodes.2008; 36: 1665-72.
  19. Miklavcic D, Semrov D, Mekid H, Mir LM. A validated model of in vivo electric field distribution in tissues for electrochemotherapy and for DNA electrotransfer for gene therapy.2000;: 73-83.
  20. Zupanic A, Corovic S, Miklavcic D, Pavlin M. Numerical optimization of gene electrotransfer into muscle tissue.2010;: 66.
  21. Kos B, Zupanic A, Kotnik T, Snoj M, Sersa G, Miklavcic D. Robustness of treatment planning for electrochemotherapy of deep-seated tumors.2010;: 147-53.
  22. Miklavcic D, Snoj M, Zupanic A, Kos B, Cemazar M, Kropivnik M, Bracko M, Pecnik T, Gadzijev E, Sersa G. Towards treatment planning and treatment of deep-seated solid tumors by electrochemotherapy.2010;: 10.
  23. Sel D, Lebar AM, Miklavcic D. Feasibility of employing model-based optimization of pulse amplitude and electrode distance for effective tumor electropermeabilization.2007;: 773-81.
  24. Rubinsky B. Irreversible electroporation. Springer.2009. pp 203-217
  25. Zupanic A, Miklavcic D. Method for treatment planning of tissue ablation by irreversible electroporation. In: Dössel O, Schlegel WC, eds.Springer Berlin Heidelberg; 2009:150-153.
  26. Edd JF, Horowitz L, Davalos RV, Mir LM, Rubinsky B. In vivo results of a new focal tissue ablation technique: Irreversible electroporation.2006;: 1409-15.
  27. Arrive L, Rosmorduc O, Dahan H, Fartoux L, Monnier-Cholley L, Lewin M, et al. Percutaneous acetic acid injection for hepatocellular carcinoma: Using ct fluoroscopy to evaluate distribution of acetic acid mixed with an iodinated contrast agent.2003;: 159-62.
  28. Duck FA.San Diego: Academic Press Inc; 1990. p. 138
  29. Elwassif MM, Kong Q, Vazquez M, Bikson M. Bio-heat transfer model of deep brain stimulation-induced temperature changes.2006;: 306-15.
  30. Laufer S, Ivorra A, Reuter VE, Rubinsky B, Solomon SB. Electrical impedance characterization of normal and cancerous human hepatic tissue.2010;: 995-1009.
  31. Sel D, Cukjati D, Batiuskaite D, Slivnik T, Mir LM, Miklavcic D. Sequential finite element model of tissue electropermeabilization.2005;: 816-27.
  32. Ivorra A, Al-Sakere B, Rubinsky B, Mir LM. In vivo electrical conductivity measurements during and after tumor electroporation: Conductivity changes reflect the treatment outcome.2009;: 5949-63.
  33. Haemmerich D, Schutt DJ, Wright AW, Webster JG, Mahvi DM. Electrical conductivity measurement of excised human metastatic liver tumours before and after thermal ablation.2009;: 459-66.
  34. Deng ZS, Liu, J. Blood perfusion-based model for characterizing the temperature fluctuation in living tissues.2001;: 521-30.
  35. Bertacchini C, Margotti PM, Bergamini E, Lodi A, Ronchetti M, Cadossi R. Design of an irreversible electroporation system for clinical use.2007;: 313-20.
  36. Edd JF, Davalos RV. Mathematical modeling of irreversible electroporation for treatment planning.2007;: 275-86.
  37. Gundersen M, Vernier PT, Marcu L, Li A, Zhu X, Gallam AZ, et al. Ultrashort pulse electroporation: Applications of high pulsed electric fields to induced caspase activation of human lymphocytes.2002
  38. Cabibbo G, Craxi A. Needle track seeding following percutaneous procedures for hepatocellular carcinoma.2009;: 62-6.
  39. Tezcan Y, Mehmet, K. Hepatocellular carcinoma with subcutaneous metastasis of the scalp.2011;: 292-5.
  40. Narayanan G. Irreversible electroporation for treatment of liver cancer.2011;: 313-6.
  41. Granot Y, Ivorra A, Maor E, Rubinsky B. In vivo imaging of irreversible electroporation by means of electrical impedance tomography.2009;: 4927-43.
  42. Zhang Y, Guo Y, Ragin AB, Lewandowski RJ, Yang GY, Nijm GM, et al. Mr imaging to assess immediate response to irreversible electroporation for targeted ablation of liver tissues: Preclinical feasibility studies in a rodent model.2010;: 424-32.
  43. Kranjc M, Bajd F, Sersa I, Miklavcic D. Magnetic resonance electrical impedance tomography for monitoring electric field distribution during tissue electroporation.2011;: 1771-8.
  44. Hjouj M, Rubinsky B. Magnetic resonance imaging characteristics of nonthermal irreversible electroporation in vegetable tissue.2010;: 137-46.
  45. Miklavcic D, Towhidi, L. Numerical study of the electroporation pulse shape effect on molecular uptake of biological cells.2010;: 34-41.
  46. Sahakian AV, Al-Angari HM, Adeyanju OO. Electrode activation sequencing employing conductivity changes in irreversible electroporation tissue ablation.2012;: 604-7.
  47. Zupanic A, Miklavcic, D. Tissue heating during tumor ablation with irreversible electroporation.2011;: 42-7.
DOI: https://doi.org/10.2478/v10019-012-0026-y | Journal eISSN: 1581-3207 | Journal ISSN: 1318-2099
Language: English
Page range: 126 - 135
Published on: Apr 19, 2012
Published by: Association of Radiology and Oncology
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year

© 2012 Oyinlolu Adeyanju, Haitham Al-Angari, Alan Sahakian, published by Association of Radiology and Oncology
This work is licensed under the Creative Commons License.